pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
dyno-therapeutics PRESS RELEASE ARCHIVE
May 19, 2023
Dyno Therapeutics Launches the Dyno bCap 1™ Capsid Product, a Breakthrough CNS Gene Delivery Vector Created with Generative Artificial Intelligence
May 2, 2023
Dyno Therapeutics to Present New Data on Optimized AAV Capsids with Transformative Therapeutic Delivery Potential at 2023 Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Dec 1, 2021
Astellas and Dyno Therapeutics Announce Research Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle
May 11, 2021
Dyno Therapeutics Presents State-of-the-Art Applications of Machine Learning to Design Improved AAV Capsids for a Broad Range of Gene Therapies at American Society of Gene and Cell Therapy Conference
May 6, 2021
Dyno Therapeutics Closes $100 Million Series A Financing Led by Andreessen Horowitz to Accelerate AI‑powered Gene Therapy Platform
Apr 27, 2021
Dyno Therapeutics Announces Presentations at 2021 American Society of Gene and Cell Therapy Annual Meeting
Apr 26, 2021
Dyno Therapeutics Names Dr. Debora Marks and Dr. Nicole Paulk to Scientific Advisory Board
Feb 11, 2021
Dyno Therapeutics Announces Publication in Nature Biotechnology Demonstrating Use of Artificial Intelligence to Generate Unprecedented Diversity of AAV Capsids and Broaden Reach of Gene Therapies
Oct 14, 2020
Dyno Therapeutics Enters Collaboration and License Agreement With Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies
May 12, 2020
Dyno Therapeutics Announces Presentations at 2020 American Society of Gene and Cell Therapy Conference
May 11, 2020
Dyno Therapeutics Emerges from Stealth to Transform Gene Therapy Using Artificial Intelligence
May 11, 2020
Dyno Therapeutics Announces Ocular Collaboration with Novartis to Develop Improved Gene Therapies with AAV Vectors based on AI Technology
Dec 2, 2019
Dyno Therapeutics Announces Research Published in Science Enabling Artificial Intelligence Approach to Create New AAV Capsids for Gene Therapies
